Market News 10 min read

Is JPM Stock a Good Investment? JPMorgan Earnings, Valuation and Key Risks

JPMorgan missed Q3 consensus at $5.75 adjusted EPS, then raised its 2026 net interest income guide to $106.2bn. The shares closed broadly flat.

A sturdy metal bridge spanning a river, with turbulent water flowing swiftly beneath while calm skies suggest stability above

JPMorgan Chase missed on earnings and raised its net interest income guidance in the same release, and the stock finished the day roughly where it started. Reporting third-quarter 2026 results before the US open on 13 October, the bank posted net income of $15.3bn, or $5.57 per diluted share. Strip out $658m of net investment securities losses and the adjusted figure was $15.8bn, or $5.75 per share — short of an adjusted consensus quoted at $5.93, with other compilers putting the Street between $5.85 and $5.94. Managed revenue was $50.9bn, up 8% year on year. And alongside the shortfall, the firm lifted its full-year 2026 net interest income outlook to about $106.2bn from $105.5bn, with NII excluding Markets raised to roughly $97.2bn from $96.5bn.

For anyone asking whether JPM stock is a good investment on the back of this print, the numbers point in two directions at once and the market's near-flat close is the honest summary. What the quarter supports is an earnings engine still running hot: NII of $27.1bn up 13%, a return on tangible common equity of 20% — 21% excluding the securities loss — investment banking fees up 14% to $3.0bn and equities revenue up 49% to $5.0bn. What would have to go right is the rate path embedded in that raised guidance. The guide is the asset here, not the print; a bank guiding NII higher is telling you where it thinks deposit costs and asset yields settle, and that is a forecast, not a result. Below we set out what the quarter did to the five factors and where the reward/risk balance now sits.

What actually happened

The quarter divides into three parts: a soft bottom line, a strong revenue mix, and a guidance raise.

On the bottom line, reported EPS of $5.57 came in below every consensus figure in circulation. The $658m of net investment securities losses reconciles the reported and adjusted numbers, and it matters which basis is quoted: $5.57 and $5.75 are the same quarter measured differently. On the adjusted basis the bank reported $5.75 against a $5.93 adjusted forecast; net income was $15.3bn reported, $15.8bn adjusted.

On revenue, the mix was the strong part:

  • Managed revenue of $50.9bn, up 8% year on year (reported revenue of $50.2bn per the 8-K)
  • Net interest income of $27.1bn, up 13%
  • Non-interest revenue of $23.8bn, up 3%
  • Investment banking fees of $3.0bn, up 14%, led by advisory
  • Equities revenue of $5.0bn, up 49%, on strength in prime and derivatives
  • Commercial & Investment Bank revenue of $22.7bn, up 14%, with net income up 20% to $8.2bn
  • ROTCE of 20%, or 21% excluding the securities loss

JPMorgan also noted it remained ranked first globally for investment banking fees, with a 9.2% year-to-date wallet share as of 1 October 2026. Management characterised markets revenue and IB fees as each rising at a mid-teens rate on strong client activity, while noting that activity moderated somewhat as the quarter progressed.

On guidance, the raise is the part that will still matter in six months. Full-year 2026 NII went to about $106.2bn from $105.5bn, and NII excluding Markets to about $97.2bn from $96.5bn. The firm also pointed to NII excluding Markets of roughly $107bn for 2027 — a forward number that extends the earnings profile into next year rather than simply tidying up this one.

Shares fell around 3% in the premarket, recovered most of that through the session, and closed at $331.43, down 0.86% from the previous close of $334.30.

Why the market reacted the way it did

Because the miss was low-quality and the guide was high-quality, and the market correctly weighted the second.

A shortfall driven by $658m of securities losses is not the same thing as a shortfall driven by weak client revenue or rising credit costs. Investment securities marks are a function of where rates and spreads moved during the quarter; they tell you something about the bank's positioning, but they are not a signal about the franchise's earning power. Underneath that item, every revenue line that reflects actual customer activity went up, and two of them — equities and advisory — went up a great deal.

Meanwhile the NII raise speaks directly to the next four quarters. Net interest income is the single largest profit driver at a bank of this shape, and raising the full-year outlook late in the year narrows the range of outcomes considerably: with three quarters already banked, a higher full-year guide is close to a statement about the fourth. Extending that into a 2027 figure of around $107bn for NII excluding Markets does more again — it says management believes the deposit repricing and asset yield dynamics that produced 13% NII growth this quarter have further to run.

So the flat close is not indifference. It is a market netting a non-operating miss against an operating upgrade and concluding they roughly cancel. The consequence: the stock now carries more forward expectation than before the print, with no price move to show for it — a subtle change in the risk profile, and the reason this quarter deserves more attention than its reaction suggests.

The Openbook read

Where the quarter leaves the five factors, and what the reward/risk picture looks like from here. The current scores sit on the JPMorgan equity page.

Momentum — neutral, and deliberately so. There is no price momentum to read from a session that closed barely changed, and we would caution against inferring any. What the quarter changed is earnings momentum rather than price momentum: NII accelerating at 13% and a raised guide are positive, an EPS line below consensus is not, and the two net to roughly nothing. This is the least informative factor this quarter, and treating the flat close as a signal in either direction would be a mistake.

Growth — stronger than the headline, concentrated in the cyclical lines. Managed revenue up 8% is good for an institution of this size, but the composition matters. Equities up 49% and advisory-led IB fees up 14% are the fastest-growing pieces, and both are the most cyclical things a bank does. Markets and banking revenue compound beautifully in an active year and shrink quickly in a quiet one. Set against that, NII up 13% is the more durable component, and it is the one being guided higher. Growth scores well; roughly half of it is sensitive to a client-activity cycle that management has already described as moderating.

Profitability — unambiguously the strongest factor. A 20% ROTCE, 21% excluding the securities loss, is the number to anchor on. It means the bank earns a fifth of its tangible equity base annually, funding the dividend, the buyback and balance sheet growth simultaneously. The CIB's 20% net income growth on 14% revenue growth shows operating leverage in the segment doing the heavy lifting. Nothing in this quarter dents Profitability.

Solvency — not the question at this bank, which is itself worth stating. JPMorgan's capital and liquidity position is the sector's reference point rather than a variable to monitor, and the quarter changed nothing. The relevant question is not the bank's own balance sheet but its borrowers': credit costs across US consumer and corporate books would move this factor, and they did not move materially. We score Solvency a strength and a non-issue.

Reward/Risk — the balance has moved from delivery to the rate path. This is where the quarter genuinely changed things. The earnings power is now substantially in the guidance rather than in the print: $106.2bn of 2026 NII and roughly $107bn of 2027 NII excluding Markets are forecasts that depend on how rates, deposit costs and asset yields evolve. If inflation data keeps the policy path higher for longer, that guide gets easier to hit on the asset side and harder on the deposit side; if the path turns down faster than expected, NII growth compresses from the top. Either way, an investor buying JPM after this print is underwriting a rate forecast more than a franchise question — the franchise question was answered by the 20% ROTCE. That is a different risk from the one the stock carried a week ago, and it is not a risk the flat close has priced.

The read-across

JPMorgan reported into the same week as its large US peers, and the cross-read is unusually clean this quarter.

The strongest signal is in trading. JPMorgan's equities revenue rose 49% to $5.0bn. Goldman Sachs, reporting the same day, posted net revenues of $18.68bn and net earnings of $5.29bn, with diluted EPS of $17.01 and equities trading revenue up 72% to $6.44bn. Two of the largest equities franchises on the Street growing that fast in the same three months is a statement about market structure — elevated client activity in prime and derivatives — rather than about either firm's share gains. It is the clearest positive to carry into the rest of the reporting season.

On net interest income the picture is more differentiated. Aggregate NII across the four largest US banks was expected to rise around 9.6% year on year to roughly $72.8bn in the third quarter, on pre-earnings estimates compiled in early October. JPMorgan's 13% puts it at the upper end of that range, which reflects its asset mix rather than a sector-wide run rate. Investors should not read JPMorgan's NII raise as a template for Wells Fargo or Citigroup, both of which carry different deposit franchises and different rate sensitivities. Wells Fargo's own third quarter came in modestly ahead of expectations on earnings per share.

The broader sector point is what gets rewarded. JPMorgan missed on EPS and was not punished, because the miss sat in securities marks and the guide went up. The market this season is pricing guidance and client-revenue trajectory, and treating non-operating items as noise. A peer that misses on credit costs or guides NII down will not get the same treatment. Compare factor profiles across the group in the Openbook screener.

What to watch next

The fourth-quarter print and the full-year NII outturn. JPMorgan typically reports Q4 and full-year results in mid-January. With the 2026 guide raised to about $106.2bn, that release is a direct test: the full-year figure either lands on the raised number or it does not, and there is only one quarter left in which to settle it. This is the single highest-information event on the calendar for this stock.

The 2027 NII trajectory as the rate path resolves. The roughly $107bn figure for NII excluding Markets in 2027 is the forward anchor. Watch for it to be reiterated, raised or trimmed at each subsequent quarter, and watch inflation prints and Federal Reserve communications in between — they are the inputs. Guidance movement on that line will matter more to the shares than any single quarter's EPS.

Client activity levels in markets and banking. Management flagged activity moderating during the quarter even as revenue rose at a mid-teens rate. Equities up 49% and advisory-led fees up 14% set a high base for next year. If activity cools further, the fastest-growing half of the revenue mix slows first, and the Growth score's durability depends on NII taking up the slack.

Credit costs. The quietest line this quarter is the one that would change the thesis fastest. Nothing suggested deterioration in consumer or corporate credit, but it is the item that turns a rate-path story into a solvency story — worth checking in every release regardless of the headline EPS.

Was this useful?
Sign in to vote
3 of 4
Compare JPM, GS, WFC